Set as Homepage - Bookmark This Page   
You are here:Home >News >Waters... noitazilaicremmoC dna tnempole Content

Waters... noitazilaicremmoC dna tnempole

Source: NEAR ProtocolEditor: NewsDate: 2025-05-21 18:52:40
Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists

0.9085s , 6839.5234375 kb

Copyright © 2025 Powered by Waters... noitazilaicremmoC dna tnempole,NEAR Protocol  

sitemap

Top